COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,363 Articles (22,803 medRxiv, 8,560 bioRxiv)

Most recent first Previous |  Page 874: Articles 8731-8740  | Next

Determinants of passive antibody effectiveness in SARS-CoV-2 infection
Stadler, E., Chai, K. L., Schlub, T. E., Cromer, D., Polizzotto, M. N., Kent, S. J., Skoetz, N., Estcourt, L. J., McQuilten, Z. K., Wood, E. M., Khoury, D. S., Davenport, M. P.
10.1101/2022.03.21.22272672 — Posted: 2022-03-22
Immunogenic superiority and safety of Biological E CORBEVAX vaccine compared to COVISHIELD (ChAdOx1 nCoV-19) vaccine studied in a phase III, single blind, multicenter, randomized clinical trial
Thuluva, S., Paradkar, V., Turaga, K., Gunneri, S., Yerroju, V., Mogulla, R. R., Pothakamuri, V. S., Kyasani, M., Manoharan, S., Adabala, S., Javvadi, A. S., Medigeshi, G. R., Singh, J., Shaman, H., Binayke, A., Zaheer, A., Awasrhi, A., Singh, C., A, V. R., Basu, I., Khobragade, A. A. K., Pandey, A. K.
10.1101/2022.03.20.22271891 — Posted: 2022-03-22
The dramatic surge of excess mortality in the United States between 2017 and 2021
Heuveline, P.
10.1101/2022.03.21.22272722 — Posted: 2022-03-22
Effect of prior infection, vaccination, and hybrid immunity against symptomatic BA.1 and BA.2 Omicron infections and severe COVID-19 in Qatar
Altarawneh, H. N., Chemaitelly, H., Ayoub, H., Tang, P., Hasan, M. R., YASSINE, H. M., Al-Khatib, H. A., Smatti, M. K., Coyle, P., Al-Kanaani, Z., Al-Kuwari, E., Jeremijenko, A., Kaleeckal, A. H., Latif, A. N., Shaik, R. M., Abdul-Rahim, H. F., Nasrallah, G., Al-Kuwari, M. G., Butt, A. A., Al-Romaihi, H. E., Al-Thani, M. H., Al-Khal, A., Bertollini, R., Abu-Raddad, L. J.
10.1101/2022.03.22.22272745 — Posted: 2022-03-22
Vaccine effectiveness of two and three doses of BNT162b2 and CoronaVac against COVID-19 in Hong Kong
McMenamin, M. E., Nealon, J., Lin, Y., Wong, J. Y., Cheung, J. K., Lau, E. H. Y., Wu, P., Leung, G. M., Cowling, B. J.
10.1101/2022.03.22.22272769 — Posted: 2022-03-22
Where the truth really lies: Listening to voices from African American communities in the Southern States about COVID-19 vaccine information and communication
Zhang, R., Qiao, S., Mckeever, B., Olatosi, B., Li, X.
10.1101/2022.03.21.22272728 — Posted: 2022-03-22
A Sliding Window Approach to Optimize the Time-varying Parameters of a Spatially-explicit and Stochastic Model of COVID-19
Ratnavale, S., Hepp, C. M., Doerry, E., Mihaljevic, J. R.
10.1101/2022.03.21.22272590 — Posted: 2022-03-22
Long-term symptoms after SARS-CoV-2 infection in a cohort of hospital employees: duration and predictive factors
Gruber, R., Montilva Ludewig, M. V., Wessels, C., Schlang, G., Jedhoff, S., Herbrandt, S., Mattner, F.
10.1101/2022.03.22.22272770 — Posted: 2022-03-22
Early detection of SARS-CoV-2 variants using traveler-based genomic surveillance at four US airports, September 2021- January 2022
Wegrzyn, R. D., Appiah, G. D., Morfino,, R., Milford, S. R., Walker, A. T., Ernst, E. T., Darrow, W. W., Li, S. L., Robison, K., MacCannell, D., Dai, D., Girinathan, B. P., Hicks, A. L., Cosca, B., Woronoff, G., Plocik, A. M., Simen, B. B., Moriarty, L., Guagliardo, S. A. J., Cetron, M. S., Friedman, C. R.
10.1101/2022.03.21.22272490 — Posted: 2022-03-22
Regional importation and asymmetric within-country spread of SARS-CoV-2 variants of concern in the Netherlands
Han, A. X., Kozanli, E., Koopsen, J., Vennema, H., RIVM COVID-19 molecular epidemiology group, , Hajji, K., Kroneman, A., van Walle, I., Klinkenberg, D., Wallinga, J., Russell, C. A., Eggink, D., Reusken, C. B. E. M.
10.1101/2022.03.21.22272611 — Posted: 2022-03-22

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).